These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 25584860

  • 1. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL.
    Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860
    [Abstract] [Full Text] [Related]

  • 2. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
    Guo H, Lai Q, Wang W, Wu Y, Zhang C, Liu Y, Yuan Z.
    Int J Pharm; 2013 Jul 15; 451(1-2):1-11. PubMed ID: 23618965
    [Abstract] [Full Text] [Related]

  • 3. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
    Zhang C, Wang W, Liu T, Wu Y, Guo H, Wang P, Tian Q, Wang Y, Yuan Z.
    Biomaterials; 2012 Mar 15; 33(7):2187-96. PubMed ID: 22169820
    [Abstract] [Full Text] [Related]

  • 4. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
    Wang X, Gu X, Wang H, Yang J, Mao S.
    Carbohydr Polym; 2018 Sep 01; 195():170-179. PubMed ID: 29804965
    [Abstract] [Full Text] [Related]

  • 5. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, Wang CH, Yuan Z, Liu M, Wan HY, Tang H.
    Biomaterials; 2010 Jun 01; 31(17):4748-56. PubMed ID: 20303163
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O, Tang Y, Ke X, Chen Y, Hu D, Tu J, Zhao L, Bourkaib N.
    Int J Pharm; 2015 Jan 30; 478(2):553-68. PubMed ID: 25455765
    [Abstract] [Full Text] [Related]

  • 7. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.
    Tian Q, Wang XH, Wang W, Zhang CN, Wang P, Yuan Z.
    Nanomedicine; 2012 Aug 30; 8(6):870-9. PubMed ID: 22100756
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q, Byeon HJ, Lee C, Lee S, Lee ES, Choi YW, Choi HG, Park ES, Lee KC, Youn YS.
    Pharm Res; 2016 Mar 30; 33(3):615-26. PubMed ID: 26526555
    [Abstract] [Full Text] [Related]

  • 9. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F, Zheng C, Xin J, Chen F, Ling H, Sun L, Webster TJ, Ming X, Liu J.
    Int J Nanomedicine; 2016 Mar 30; 11():3875-90. PubMed ID: 27574421
    [Abstract] [Full Text] [Related]

  • 10. Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier.
    Yang W, Zhang Y, Wang J, Li H, Yang H.
    Int J Biol Macromol; 2022 Sep 01; 216():789-798. PubMed ID: 35914549
    [Abstract] [Full Text] [Related]

  • 11. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.
    Wang FZ, Xing L, Tang ZH, Lu JJ, Cui PF, Qiao JB, Jiang L, Jiang HL, Zong L.
    Mol Pharm; 2016 Apr 04; 13(4):1298-307. PubMed ID: 26894988
    [Abstract] [Full Text] [Related]

  • 12. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
    Zhang Y, Cui Z, Mei H, Xu J, Zhou T, Cheng F, Wang K.
    Carbohydr Polym; 2019 Sep 01; 219():143-154. PubMed ID: 31151511
    [Abstract] [Full Text] [Related]

  • 13. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance.
    Liu Y, Zhou Z, Lin X, Xiong X, Zhou R, Zhou M, Huang Y.
    Biomacromolecules; 2019 Oct 14; 20(10):3755-3766. PubMed ID: 31465208
    [Abstract] [Full Text] [Related]

  • 14. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y, Xing H, Song F, Yang Y, Qiu Z, Lu X, Liu Q, Ren S, Chen X, Li N.
    J Pharm Sci; 2016 Sep 14; 105(9):2949-2958. PubMed ID: 27209461
    [Abstract] [Full Text] [Related]

  • 15. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
    Yang T, Lan Y, Cao M, Ma X, Cao A, Sun Y, Yang J, Li L, Liu Y.
    Colloids Surf B Biointerfaces; 2019 Mar 01; 175():106-115. PubMed ID: 30529816
    [Abstract] [Full Text] [Related]

  • 16. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J, Tao W, Chen Y, Chang D, Wang T, Zhang X, Mei L, Zeng X, Huang L.
    J Mater Sci Mater Med; 2015 Apr 01; 26(4):165. PubMed ID: 25791459
    [Abstract] [Full Text] [Related]

  • 17. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H, Liu M, Yu A, Ji J, Zhai G.
    Int J Pharm; 2017 May 15; 523(1):427-438. PubMed ID: 28359815
    [Abstract] [Full Text] [Related]

  • 18. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.
    Eur J Pharm Biopharm; 2010 Sep 15; 76(1):10-6. PubMed ID: 20472060
    [Abstract] [Full Text] [Related]

  • 19. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L, Yao J, Zhou J, Wang T, Zhang Q.
    Int J Pharm; 2013 Jan 30; 441(1-2):654-64. PubMed ID: 23117024
    [Abstract] [Full Text] [Related]

  • 20. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY, Chung SJ, Cho HJ, Kim DD.
    Eur J Pharm Biopharm; 2015 Aug 30; 94():532-41. PubMed ID: 26149228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.